Status:
COMPLETED
CMO Letter to Reduce Unnecessary Antibiotic Prescribing and Broad Spectrum Prescribing Winter 2018-9
Lead Sponsor:
Public Health England
Conditions:
Prescribing, Off-Label
Eligibility:
All Genders
Phase:
NA
Brief Summary
This trial aims to reduce unnecessary prescription of antibiotics and broad spectrum antibiotics by general practitioners (GPs) in England. Unnecessary prescriptions are defined as those that do not i...
Eligibility Criteria
Inclusion
- GP practices that prescribed more than 1.161 Antibacterial Items/STAR-PU for the twelve months (June 2017 - May 2018)
- GP practices that prescribed more than 0.965 Antibacterial Items/STAR-PU and also more than 10% broad spectrum items for the twelve months (June 2017 - May 2018).
Exclusion
- none
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2019
Estimated Enrollment :
7000 Patients enrolled
Trial Details
Trial ID
NCT03862794
Start Date
November 1 2018
End Date
May 30 2019
Last Update
March 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Public Health England
London, United Kingdom, SE1